Jim Brown, sales manager, Westfield Medical, Hospital UK sector, examines the requirement to inhibit hydrophobic proteins from adhering to surgical instruments and to reduce the risk of healthcare associated infections.
It is over 18 months since the deadline for implementation of guidance was expected “for providers whose instruments are likely to come into contact with higher risk tissues”, with “all healthcare providers engaged in the management and decontamination of surgical instruments used in acute care will be expected to have implemented this guidance by 1 July 2018.”1
HTM01-01 clearly states in the introduction that “decontamination policy should demonstrate that it complies with guidance establishing essential quality requirements and a plan is in place for progression to best practice.”
How does the HTM guidance expect you to have achieved this? “Continuous improvement plans SSDs should have in place a plan of continuous process improvement. This plan should be carried out as part of a risk management plan (see BS EN ISO 14971 on medical device risk management). There should also be a specific record that relates to residual protein trend analysis.”
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
